nodes	percent_of_prediction	percent_of_DWPC	metapath
Sirolimus—FGF2—coronary artery disease	0.3	1	CbGaD
Sirolimus—SLCO1B1—Gemfibrozil—coronary artery disease	0.0266	0.0608	CbGbCtD
Sirolimus—SLCO1B1—Olmesartan—coronary artery disease	0.0252	0.0576	CbGbCtD
Sirolimus—SLCO1B1—Pitavastatin—coronary artery disease	0.0201	0.0461	CbGbCtD
Sirolimus—SLCO1B1—Valsartan—coronary artery disease	0.0196	0.0448	CbGbCtD
Sirolimus—SLCO1B1—Ezetimibe—coronary artery disease	0.0148	0.034	CbGbCtD
Sirolimus—SLCO1B1—Rosuvastatin—coronary artery disease	0.0148	0.034	CbGbCtD
Sirolimus—SLCO1B1—Simvastatin—coronary artery disease	0.0138	0.0316	CbGbCtD
Sirolimus—SLCO1B1—Pravastatin—coronary artery disease	0.0135	0.0309	CbGbCtD
Sirolimus—SLCO1B1—Lovastatin—coronary artery disease	0.0135	0.0309	CbGbCtD
Sirolimus—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.0126	0.0287	CbGbCtD
Sirolimus—CYP3A7—Eplerenone—coronary artery disease	0.0126	0.0287	CbGbCtD
Sirolimus—SLCO1B1—Atorvastatin—coronary artery disease	0.0123	0.0281	CbGbCtD
Sirolimus—SLCO1B1—Losartan—coronary artery disease	0.0112	0.0257	CbGbCtD
Sirolimus—ABCB1—Ticagrelor—coronary artery disease	0.0107	0.0244	CbGbCtD
Sirolimus—CYP3A5—Clopidogrel—coronary artery disease	0.0101	0.0232	CbGbCtD
Sirolimus—CYP3A5—Eplerenone—coronary artery disease	0.00942	0.0216	CbGbCtD
Sirolimus—CYP3A7—Simvastatin—coronary artery disease	0.00809	0.0185	CbGbCtD
Sirolimus—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.00809	0.0185	CbGbCtD
Sirolimus—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.00792	0.0181	CbGbCtD
Sirolimus—CYP3A7—Lovastatin—coronary artery disease	0.00792	0.0181	CbGbCtD
Sirolimus—CYP3A7—Atorvastatin—coronary artery disease	0.00721	0.0165	CbGbCtD
Sirolimus—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.00721	0.0165	CbGbCtD
Sirolimus—ABCB1—Perindopril—coronary artery disease	0.00659	0.0151	CbGbCtD
Sirolimus—ABCB1—Clopidogrel—coronary artery disease	0.00659	0.0151	CbGbCtD
Sirolimus—CYP3A5—Rosuvastatin—coronary artery disease	0.00653	0.0149	CbGbCtD
Sirolimus—CYP3A4—Ticagrelor—coronary artery disease	0.00639	0.0146	CbGbCtD
Sirolimus—CYP3A5—Simvastatin—coronary artery disease	0.00607	0.0139	CbGbCtD
Sirolimus—CYP3A5—Lovastatin—coronary artery disease	0.00594	0.0136	CbGbCtD
Sirolimus—CYP3A5—Pravastatin—coronary artery disease	0.00594	0.0136	CbGbCtD
Sirolimus—ABCB1—Telmisartan—coronary artery disease	0.00576	0.0132	CbGbCtD
Sirolimus—ABCB1—Pitavastatin—coronary artery disease	0.00576	0.0132	CbGbCtD
Sirolimus—CYP3A4—Fenofibrate—coronary artery disease	0.0057	0.013	CbGbCtD
Sirolimus—ABCB1—Enalapril—coronary artery disease	0.00546	0.0125	CbGbCtD
Sirolimus—ABCB1—Lisinopril—coronary artery disease	0.00546	0.0125	CbGbCtD
Sirolimus—CYP3A5—Atorvastatin—coronary artery disease	0.00541	0.0124	CbGbCtD
Sirolimus—CYP3A5—Losartan—coronary artery disease	0.00495	0.0113	CbGbCtD
Sirolimus—ABCB1—Timolol—coronary artery disease	0.00465	0.0106	CbGbCtD
Sirolimus—CYP3A4—Gemfibrozil—coronary artery disease	0.00456	0.0104	CbGbCtD
Sirolimus—ABCB1—Ezetimibe—coronary artery disease	0.00425	0.00973	CbGbCtD
Sirolimus—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00414	0.00948	CbGbCtD
Sirolimus—ABCB1—Captopril—coronary artery disease	0.00409	0.00936	CbGbCtD
Sirolimus—CYP3A4—Clopidogrel—coronary artery disease	0.00395	0.00904	CbGbCtD
Sirolimus—ABCB1—Simvastatin—coronary artery disease	0.00395	0.00904	CbGbCtD
Sirolimus—ABCB1—Lovastatin—coronary artery disease	0.00387	0.00885	CbGbCtD
Sirolimus—ABCB1—Pravastatin—coronary artery disease	0.00387	0.00885	CbGbCtD
Sirolimus—CYP3A4—Eplerenone—coronary artery disease	0.00367	0.00841	CbGbCtD
Sirolimus—ABCB1—Atorvastatin—coronary artery disease	0.00352	0.00806	CbGbCtD
Sirolimus—CYP3A4—Enalapril—coronary artery disease	0.00327	0.00749	CbGbCtD
Sirolimus—ABCB1—Losartan—coronary artery disease	0.00322	0.00737	CbGbCtD
Sirolimus—CYP3A4—Rosuvastatin—coronary artery disease	0.00255	0.00583	CbGbCtD
Sirolimus—CYP3A4—Ezetimibe—coronary artery disease	0.00255	0.00583	CbGbCtD
Sirolimus—CYP3A4—Simvastatin—coronary artery disease	0.00237	0.00542	CbGbCtD
Sirolimus—CYP3A4—Lovastatin—coronary artery disease	0.00232	0.0053	CbGbCtD
Sirolimus—CYP3A4—Pravastatin—coronary artery disease	0.00232	0.0053	CbGbCtD
Sirolimus—CYP3A4—Atorvastatin—coronary artery disease	0.00211	0.00483	CbGbCtD
Sirolimus—CYP3A4—Losartan—coronary artery disease	0.00193	0.00442	CbGbCtD
Sirolimus—EIF4E—heart—coronary artery disease	0.00099	0.129	CbGeAlD
Sirolimus—EIF4E—cardiovascular system—coronary artery disease	0.000935	0.122	CbGeAlD
Sirolimus—EIF4E—blood—coronary artery disease	0.000739	0.0962	CbGeAlD
Sirolimus—FGF2—heart—coronary artery disease	0.000604	0.0786	CbGeAlD
Sirolimus—FKBP1A—cardiac ventricle—coronary artery disease	0.000525	0.0683	CbGeAlD
Sirolimus—FKBP1A—myocardium—coronary artery disease	0.000494	0.0642	CbGeAlD
Sirolimus—MTOR—heart—coronary artery disease	0.000383	0.0499	CbGeAlD
Sirolimus—MTOR—cardiovascular system—coronary artery disease	0.000362	0.047	CbGeAlD
Sirolimus—FKBP1A—heart—coronary artery disease	0.000345	0.0448	CbGeAlD
Sirolimus—FKBP1A—cardiovascular system—coronary artery disease	0.000325	0.0423	CbGeAlD
Sirolimus—SLC47A1—heart—coronary artery disease	0.000296	0.0385	CbGeAlD
Sirolimus—FKBP1A—cardiac atrium—coronary artery disease	0.000295	0.0384	CbGeAlD
Sirolimus—MTOR—blood—coronary artery disease	0.000286	0.0372	CbGeAlD
Sirolimus—FKBP1A—blood—coronary artery disease	0.000257	0.0335	CbGeAlD
Sirolimus—SLC47A1—blood—coronary artery disease	0.000221	0.0288	CbGeAlD
Sirolimus—SLCO1B1—blood—coronary artery disease	0.000218	0.0284	CbGeAlD
Sirolimus—CYP3A5—blood—coronary artery disease	0.000112	0.0146	CbGeAlD
Sirolimus—CYP3A4—blood—coronary artery disease	8.4e-05	0.0109	CbGeAlD
Sirolimus—ABCB1—heart—coronary artery disease	7.97e-05	0.0104	CbGeAlD
Sirolimus—ABCB1—cardiovascular system—coronary artery disease	7.52e-05	0.00979	CbGeAlD
Sirolimus—ABCB1—blood—coronary artery disease	5.95e-05	0.00774	CbGeAlD
Sirolimus—Pruritus—Olmesartan—coronary artery disease	2.87e-05	0.00019	CcSEcCtD
Sirolimus—Decreased appetite—Losartan—coronary artery disease	2.86e-05	0.00019	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	2.86e-05	0.00019	CcSEcCtD
Sirolimus—Abdominal pain—Captopril—coronary artery disease	2.86e-05	0.00019	CcSEcCtD
Sirolimus—Body temperature increased—Captopril—coronary artery disease	2.86e-05	0.00019	CcSEcCtD
Sirolimus—Dizziness—Simvastatin—coronary artery disease	2.85e-05	0.000189	CcSEcCtD
Sirolimus—Rash—Ezetimibe—coronary artery disease	2.85e-05	0.000189	CcSEcCtD
Sirolimus—Dermatitis—Ezetimibe—coronary artery disease	2.85e-05	0.000189	CcSEcCtD
Sirolimus—Confusional state—Ramipril—coronary artery disease	2.85e-05	0.000189	CcSEcCtD
Sirolimus—Discomfort—Timolol—coronary artery disease	2.85e-05	0.000189	CcSEcCtD
Sirolimus—Asthenia—Niacin—coronary artery disease	2.84e-05	0.000189	CcSEcCtD
Sirolimus—Headache—Ezetimibe—coronary artery disease	2.83e-05	0.000188	CcSEcCtD
Sirolimus—Malaise—Lisinopril—coronary artery disease	2.83e-05	0.000188	CcSEcCtD
Sirolimus—Anaphylactic shock—Ramipril—coronary artery disease	2.82e-05	0.000188	CcSEcCtD
Sirolimus—Oedema—Ramipril—coronary artery disease	2.82e-05	0.000188	CcSEcCtD
Sirolimus—Constipation—Losartan—coronary artery disease	2.82e-05	0.000187	CcSEcCtD
Sirolimus—Pain—Losartan—coronary artery disease	2.82e-05	0.000187	CcSEcCtD
Sirolimus—Syncope—Lisinopril—coronary artery disease	2.82e-05	0.000187	CcSEcCtD
Sirolimus—Vomiting—Eplerenone—coronary artery disease	2.81e-05	0.000187	CcSEcCtD
Sirolimus—Feeling abnormal—Furosemide—coronary artery disease	2.81e-05	0.000187	CcSEcCtD
Sirolimus—Leukopenia—Lisinopril—coronary artery disease	2.81e-05	0.000187	CcSEcCtD
Sirolimus—Nausea—Fenofibrate—coronary artery disease	2.81e-05	0.000186	CcSEcCtD
Sirolimus—Pruritus—Niacin—coronary artery disease	2.8e-05	0.000186	CcSEcCtD
Sirolimus—Asthenia—Pravastatin—coronary artery disease	2.8e-05	0.000186	CcSEcCtD
Sirolimus—Gastrointestinal pain—Furosemide—coronary artery disease	2.79e-05	0.000185	CcSEcCtD
Sirolimus—Rash—Eplerenone—coronary artery disease	2.79e-05	0.000185	CcSEcCtD
Sirolimus—Hypersensitivity—Trandolapril—coronary artery disease	2.79e-05	0.000185	CcSEcCtD
Sirolimus—Dermatitis—Eplerenone—coronary artery disease	2.79e-05	0.000185	CcSEcCtD
Sirolimus—Diarrhoea—Valsartan—coronary artery disease	2.79e-05	0.000185	CcSEcCtD
Sirolimus—Confusional state—Timolol—coronary artery disease	2.78e-05	0.000185	CcSEcCtD
Sirolimus—Shock—Ramipril—coronary artery disease	2.78e-05	0.000185	CcSEcCtD
Sirolimus—Hypersensitivity—Enalapril—coronary artery disease	2.78e-05	0.000185	CcSEcCtD
Sirolimus—Body temperature increased—Perindopril—coronary artery disease	2.78e-05	0.000184	CcSEcCtD
Sirolimus—Abdominal pain—Perindopril—coronary artery disease	2.78e-05	0.000184	CcSEcCtD
Sirolimus—Palpitations—Lisinopril—coronary artery disease	2.77e-05	0.000184	CcSEcCtD
Sirolimus—Diarrhoea—Olmesartan—coronary artery disease	2.77e-05	0.000184	CcSEcCtD
Sirolimus—Headache—Eplerenone—coronary artery disease	2.77e-05	0.000184	CcSEcCtD
Sirolimus—Nervous system disorder—Ramipril—coronary artery disease	2.77e-05	0.000184	CcSEcCtD
Sirolimus—Thrombocytopenia—Ramipril—coronary artery disease	2.77e-05	0.000184	CcSEcCtD
Sirolimus—Oedema—Timolol—coronary artery disease	2.76e-05	0.000183	CcSEcCtD
Sirolimus—Anaphylactic shock—Timolol—coronary artery disease	2.76e-05	0.000183	CcSEcCtD
Sirolimus—Pruritus—Pravastatin—coronary artery disease	2.76e-05	0.000183	CcSEcCtD
Sirolimus—Loss of consciousness—Lisinopril—coronary artery disease	2.76e-05	0.000183	CcSEcCtD
Sirolimus—Nausea—Clopidogrel—coronary artery disease	2.76e-05	0.000183	CcSEcCtD
Sirolimus—Tachycardia—Ramipril—coronary artery disease	2.76e-05	0.000183	CcSEcCtD
Sirolimus—Skin disorder—Ramipril—coronary artery disease	2.74e-05	0.000182	CcSEcCtD
Sirolimus—Infection—Timolol—coronary artery disease	2.74e-05	0.000182	CcSEcCtD
Sirolimus—Vomiting—Simvastatin—coronary artery disease	2.74e-05	0.000182	CcSEcCtD
Sirolimus—Hypersensitivity—Telmisartan—coronary artery disease	2.74e-05	0.000182	CcSEcCtD
Sirolimus—Cough—Lisinopril—coronary artery disease	2.74e-05	0.000182	CcSEcCtD
Sirolimus—Nausea—Lovastatin—coronary artery disease	2.74e-05	0.000182	CcSEcCtD
Sirolimus—Hyperhidrosis—Ramipril—coronary artery disease	2.73e-05	0.000181	CcSEcCtD
Sirolimus—Rash—Simvastatin—coronary artery disease	2.72e-05	0.000181	CcSEcCtD
Sirolimus—Dermatitis—Simvastatin—coronary artery disease	2.72e-05	0.00018	CcSEcCtD
Sirolimus—Asthenia—Trandolapril—coronary artery disease	2.72e-05	0.00018	CcSEcCtD
Sirolimus—Shock—Timolol—coronary artery disease	2.72e-05	0.00018	CcSEcCtD
Sirolimus—Feeling abnormal—Losartan—coronary artery disease	2.71e-05	0.00018	CcSEcCtD
Sirolimus—Diarrhoea—Niacin—coronary artery disease	2.71e-05	0.00018	CcSEcCtD
Sirolimus—Nervous system disorder—Timolol—coronary artery disease	2.71e-05	0.00018	CcSEcCtD
Sirolimus—Asthenia—Enalapril—coronary artery disease	2.71e-05	0.00018	CcSEcCtD
Sirolimus—Headache—Simvastatin—coronary artery disease	2.7e-05	0.000179	CcSEcCtD
Sirolimus—Abdominal pain—Furosemide—coronary artery disease	2.7e-05	0.000179	CcSEcCtD
Sirolimus—Body temperature increased—Furosemide—coronary artery disease	2.7e-05	0.000179	CcSEcCtD
Sirolimus—Gastrointestinal pain—Losartan—coronary artery disease	2.69e-05	0.000179	CcSEcCtD
Sirolimus—Dizziness—Valsartan—coronary artery disease	2.69e-05	0.000179	CcSEcCtD
Sirolimus—Anorexia—Ramipril—coronary artery disease	2.69e-05	0.000179	CcSEcCtD
Sirolimus—Nausea—Ezetimibe—coronary artery disease	2.69e-05	0.000178	CcSEcCtD
Sirolimus—Skin disorder—Timolol—coronary artery disease	2.68e-05	0.000178	CcSEcCtD
Sirolimus—Dizziness—Olmesartan—coronary artery disease	2.68e-05	0.000178	CcSEcCtD
Sirolimus—Pruritus—Trandolapril—coronary artery disease	2.68e-05	0.000178	CcSEcCtD
Sirolimus—Arthralgia—Lisinopril—coronary artery disease	2.67e-05	0.000177	CcSEcCtD
Sirolimus—Myalgia—Lisinopril—coronary artery disease	2.67e-05	0.000177	CcSEcCtD
Sirolimus—Chest pain—Lisinopril—coronary artery disease	2.67e-05	0.000177	CcSEcCtD
Sirolimus—Hyperhidrosis—Timolol—coronary artery disease	2.67e-05	0.000177	CcSEcCtD
Sirolimus—Asthenia—Telmisartan—coronary artery disease	2.67e-05	0.000177	CcSEcCtD
Sirolimus—Pruritus—Enalapril—coronary artery disease	2.67e-05	0.000177	CcSEcCtD
Sirolimus—Diarrhoea—Pravastatin—coronary artery disease	2.67e-05	0.000177	CcSEcCtD
Sirolimus—Anxiety—Lisinopril—coronary artery disease	2.66e-05	0.000177	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	2.65e-05	0.000176	CcSEcCtD
Sirolimus—Discomfort—Lisinopril—coronary artery disease	2.64e-05	0.000175	CcSEcCtD
Sirolimus—Hypotension—Ramipril—coronary artery disease	2.64e-05	0.000175	CcSEcCtD
Sirolimus—Anorexia—Timolol—coronary artery disease	2.63e-05	0.000175	CcSEcCtD
Sirolimus—Pruritus—Telmisartan—coronary artery disease	2.63e-05	0.000175	CcSEcCtD
Sirolimus—Nausea—Eplerenone—coronary artery disease	2.63e-05	0.000175	CcSEcCtD
Sirolimus—Dizziness—Niacin—coronary artery disease	2.62e-05	0.000174	CcSEcCtD
Sirolimus—Body temperature increased—Losartan—coronary artery disease	2.6e-05	0.000173	CcSEcCtD
Sirolimus—Abdominal pain—Losartan—coronary artery disease	2.6e-05	0.000173	CcSEcCtD
Sirolimus—Asthenia—Captopril—coronary artery disease	2.6e-05	0.000172	CcSEcCtD
Sirolimus—Diarrhoea—Trandolapril—coronary artery disease	2.59e-05	0.000172	CcSEcCtD
Sirolimus—Vomiting—Valsartan—coronary artery disease	2.59e-05	0.000172	CcSEcCtD
Sirolimus—Confusional state—Lisinopril—coronary artery disease	2.58e-05	0.000172	CcSEcCtD
Sirolimus—Diarrhoea—Enalapril—coronary artery disease	2.58e-05	0.000171	CcSEcCtD
Sirolimus—Hypotension—Timolol—coronary artery disease	2.58e-05	0.000171	CcSEcCtD
Sirolimus—Dizziness—Pravastatin—coronary artery disease	2.58e-05	0.000171	CcSEcCtD
Sirolimus—Vomiting—Olmesartan—coronary artery disease	2.58e-05	0.000171	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.57e-05	0.000171	CcSEcCtD
Sirolimus—Rash—Valsartan—coronary artery disease	2.57e-05	0.000171	CcSEcCtD
Sirolimus—Dermatitis—Valsartan—coronary artery disease	2.57e-05	0.00017	CcSEcCtD
Sirolimus—Nausea—Simvastatin—coronary artery disease	2.56e-05	0.00017	CcSEcCtD
Sirolimus—Anaphylactic shock—Lisinopril—coronary artery disease	2.56e-05	0.00017	CcSEcCtD
Sirolimus—Oedema—Lisinopril—coronary artery disease	2.56e-05	0.00017	CcSEcCtD
Sirolimus—Pruritus—Captopril—coronary artery disease	2.56e-05	0.00017	CcSEcCtD
Sirolimus—Rash—Olmesartan—coronary artery disease	2.56e-05	0.00017	CcSEcCtD
Sirolimus—Insomnia—Ramipril—coronary artery disease	2.56e-05	0.00017	CcSEcCtD
Sirolimus—Dermatitis—Olmesartan—coronary artery disease	2.55e-05	0.00017	CcSEcCtD
Sirolimus—Headache—Valsartan—coronary artery disease	2.55e-05	0.000169	CcSEcCtD
Sirolimus—Diarrhoea—Telmisartan—coronary artery disease	2.55e-05	0.000169	CcSEcCtD
Sirolimus—Infection—Lisinopril—coronary artery disease	2.55e-05	0.000169	CcSEcCtD
Sirolimus—Headache—Olmesartan—coronary artery disease	2.54e-05	0.000169	CcSEcCtD
Sirolimus—Paraesthesia—Ramipril—coronary artery disease	2.54e-05	0.000168	CcSEcCtD
Sirolimus—Shock—Lisinopril—coronary artery disease	2.52e-05	0.000167	CcSEcCtD
Sirolimus—Asthenia—Perindopril—coronary artery disease	2.52e-05	0.000167	CcSEcCtD
Sirolimus—Dyspnoea—Ramipril—coronary artery disease	2.52e-05	0.000167	CcSEcCtD
Sirolimus—Vomiting—Niacin—coronary artery disease	2.52e-05	0.000167	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Timolol—coronary artery disease	2.52e-05	0.000167	CcSEcCtD
Sirolimus—Hypersensitivity—Furosemide—coronary artery disease	2.52e-05	0.000167	CcSEcCtD
Sirolimus—Somnolence—Ramipril—coronary artery disease	2.51e-05	0.000167	CcSEcCtD
Sirolimus—Thrombocytopenia—Lisinopril—coronary artery disease	2.51e-05	0.000167	CcSEcCtD
Sirolimus—Dizziness—Trandolapril—coronary artery disease	2.5e-05	0.000166	CcSEcCtD
Sirolimus—Tachycardia—Lisinopril—coronary artery disease	2.5e-05	0.000166	CcSEcCtD
Sirolimus—Insomnia—Timolol—coronary artery disease	2.5e-05	0.000166	CcSEcCtD
Sirolimus—Rash—Niacin—coronary artery disease	2.5e-05	0.000166	CcSEcCtD
Sirolimus—Dermatitis—Niacin—coronary artery disease	2.5e-05	0.000166	CcSEcCtD
Sirolimus—Dizziness—Enalapril—coronary artery disease	2.49e-05	0.000166	CcSEcCtD
Sirolimus—Skin disorder—Lisinopril—coronary artery disease	2.49e-05	0.000165	CcSEcCtD
Sirolimus—Dyspepsia—Ramipril—coronary artery disease	2.49e-05	0.000165	CcSEcCtD
Sirolimus—Pruritus—Perindopril—coronary artery disease	2.49e-05	0.000165	CcSEcCtD
Sirolimus—Headache—Niacin—coronary artery disease	2.48e-05	0.000165	CcSEcCtD
Sirolimus—Paraesthesia—Timolol—coronary artery disease	2.48e-05	0.000165	CcSEcCtD
Sirolimus—Vomiting—Pravastatin—coronary artery disease	2.48e-05	0.000165	CcSEcCtD
Sirolimus—Hyperhidrosis—Lisinopril—coronary artery disease	2.48e-05	0.000164	CcSEcCtD
Sirolimus—Diarrhoea—Captopril—coronary artery disease	2.48e-05	0.000164	CcSEcCtD
Sirolimus—Dyspnoea—Timolol—coronary artery disease	2.46e-05	0.000163	CcSEcCtD
Sirolimus—Dizziness—Telmisartan—coronary artery disease	2.46e-05	0.000163	CcSEcCtD
Sirolimus—Rash—Pravastatin—coronary artery disease	2.46e-05	0.000163	CcSEcCtD
Sirolimus—Dermatitis—Pravastatin—coronary artery disease	2.46e-05	0.000163	CcSEcCtD
Sirolimus—Decreased appetite—Ramipril—coronary artery disease	2.46e-05	0.000163	CcSEcCtD
Sirolimus—Somnolence—Timolol—coronary artery disease	2.46e-05	0.000163	CcSEcCtD
Sirolimus—Asthenia—Furosemide—coronary artery disease	2.45e-05	0.000163	CcSEcCtD
Sirolimus—Headache—Pravastatin—coronary artery disease	2.44e-05	0.000162	CcSEcCtD
Sirolimus—Anorexia—Lisinopril—coronary artery disease	2.44e-05	0.000162	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Ramipril—coronary artery disease	2.44e-05	0.000162	CcSEcCtD
Sirolimus—Dyspepsia—Timolol—coronary artery disease	2.43e-05	0.000161	CcSEcCtD
Sirolimus—Hypersensitivity—Losartan—coronary artery disease	2.43e-05	0.000161	CcSEcCtD
Sirolimus—Nausea—Valsartan—coronary artery disease	2.42e-05	0.000161	CcSEcCtD
Sirolimus—Pruritus—Furosemide—coronary artery disease	2.42e-05	0.00016	CcSEcCtD
Sirolimus—Constipation—Ramipril—coronary artery disease	2.42e-05	0.00016	CcSEcCtD
Sirolimus—Nausea—Olmesartan—coronary artery disease	2.41e-05	0.00016	CcSEcCtD
Sirolimus—Vomiting—Trandolapril—coronary artery disease	2.41e-05	0.00016	CcSEcCtD
Sirolimus—Diarrhoea—Perindopril—coronary artery disease	2.4e-05	0.00016	CcSEcCtD
Sirolimus—Decreased appetite—Timolol—coronary artery disease	2.4e-05	0.000159	CcSEcCtD
Sirolimus—Vomiting—Enalapril—coronary artery disease	2.4e-05	0.000159	CcSEcCtD
Sirolimus—Hypotension—Lisinopril—coronary artery disease	2.39e-05	0.000159	CcSEcCtD
Sirolimus—Dizziness—Captopril—coronary artery disease	2.39e-05	0.000159	CcSEcCtD
Sirolimus—Rash—Trandolapril—coronary artery disease	2.39e-05	0.000159	CcSEcCtD
Sirolimus—Dermatitis—Trandolapril—coronary artery disease	2.39e-05	0.000158	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Timolol—coronary artery disease	2.38e-05	0.000158	CcSEcCtD
Sirolimus—Rash—Enalapril—coronary artery disease	2.38e-05	0.000158	CcSEcCtD
Sirolimus—Dermatitis—Enalapril—coronary artery disease	2.38e-05	0.000158	CcSEcCtD
Sirolimus—Headache—Trandolapril—coronary artery disease	2.37e-05	0.000158	CcSEcCtD
Sirolimus—Vomiting—Telmisartan—coronary artery disease	2.37e-05	0.000157	CcSEcCtD
Sirolimus—Asthenia—Losartan—coronary artery disease	2.36e-05	0.000157	CcSEcCtD
Sirolimus—Headache—Enalapril—coronary artery disease	2.36e-05	0.000157	CcSEcCtD
Sirolimus—Pain—Timolol—coronary artery disease	2.36e-05	0.000157	CcSEcCtD
Sirolimus—Nausea—Niacin—coronary artery disease	2.35e-05	0.000156	CcSEcCtD
Sirolimus—Rash—Telmisartan—coronary artery disease	2.35e-05	0.000156	CcSEcCtD
Sirolimus—Dermatitis—Telmisartan—coronary artery disease	2.34e-05	0.000156	CcSEcCtD
Sirolimus—Diarrhoea—Furosemide—coronary artery disease	2.34e-05	0.000155	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.33e-05	0.000155	CcSEcCtD
Sirolimus—Pruritus—Losartan—coronary artery disease	2.33e-05	0.000155	CcSEcCtD
Sirolimus—Headache—Telmisartan—coronary artery disease	2.33e-05	0.000155	CcSEcCtD
Sirolimus—Feeling abnormal—Ramipril—coronary artery disease	2.33e-05	0.000155	CcSEcCtD
Sirolimus—Dizziness—Perindopril—coronary artery disease	2.32e-05	0.000154	CcSEcCtD
Sirolimus—Insomnia—Lisinopril—coronary artery disease	2.32e-05	0.000154	CcSEcCtD
Sirolimus—Nausea—Pravastatin—coronary artery disease	2.32e-05	0.000154	CcSEcCtD
Sirolimus—Gastrointestinal pain—Ramipril—coronary artery disease	2.31e-05	0.000153	CcSEcCtD
Sirolimus—Paraesthesia—Lisinopril—coronary artery disease	2.3e-05	0.000153	CcSEcCtD
Sirolimus—Vomiting—Captopril—coronary artery disease	2.3e-05	0.000153	CcSEcCtD
Sirolimus—Dyspnoea—Lisinopril—coronary artery disease	2.28e-05	0.000152	CcSEcCtD
Sirolimus—Rash—Captopril—coronary artery disease	2.28e-05	0.000151	CcSEcCtD
Sirolimus—Dermatitis—Captopril—coronary artery disease	2.28e-05	0.000151	CcSEcCtD
Sirolimus—Somnolence—Lisinopril—coronary artery disease	2.28e-05	0.000151	CcSEcCtD
Sirolimus—Feeling abnormal—Timolol—coronary artery disease	2.28e-05	0.000151	CcSEcCtD
Sirolimus—Headache—Captopril—coronary artery disease	2.27e-05	0.00015	CcSEcCtD
Sirolimus—Gastrointestinal pain—Timolol—coronary artery disease	2.26e-05	0.00015	CcSEcCtD
Sirolimus—Dizziness—Furosemide—coronary artery disease	2.26e-05	0.00015	CcSEcCtD
Sirolimus—Dyspepsia—Lisinopril—coronary artery disease	2.26e-05	0.00015	CcSEcCtD
Sirolimus—Diarrhoea—Losartan—coronary artery disease	2.25e-05	0.00015	CcSEcCtD
Sirolimus—Nausea—Trandolapril—coronary artery disease	2.25e-05	0.000149	CcSEcCtD
Sirolimus—Nausea—Enalapril—coronary artery disease	2.24e-05	0.000149	CcSEcCtD
Sirolimus—Vomiting—Perindopril—coronary artery disease	2.23e-05	0.000148	CcSEcCtD
Sirolimus—Abdominal pain—Ramipril—coronary artery disease	2.23e-05	0.000148	CcSEcCtD
Sirolimus—Body temperature increased—Ramipril—coronary artery disease	2.23e-05	0.000148	CcSEcCtD
Sirolimus—Decreased appetite—Lisinopril—coronary artery disease	2.23e-05	0.000148	CcSEcCtD
Sirolimus—Rash—Perindopril—coronary artery disease	2.21e-05	0.000147	CcSEcCtD
Sirolimus—Dermatitis—Perindopril—coronary artery disease	2.21e-05	0.000147	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.21e-05	0.000147	CcSEcCtD
Sirolimus—Nausea—Telmisartan—coronary artery disease	2.21e-05	0.000147	CcSEcCtD
Sirolimus—Headache—Perindopril—coronary artery disease	2.2e-05	0.000146	CcSEcCtD
Sirolimus—Constipation—Lisinopril—coronary artery disease	2.19e-05	0.000145	CcSEcCtD
Sirolimus—Pain—Lisinopril—coronary artery disease	2.19e-05	0.000145	CcSEcCtD
Sirolimus—Abdominal pain—Timolol—coronary artery disease	2.18e-05	0.000145	CcSEcCtD
Sirolimus—Body temperature increased—Timolol—coronary artery disease	2.18e-05	0.000145	CcSEcCtD
Sirolimus—Dizziness—Losartan—coronary artery disease	2.18e-05	0.000145	CcSEcCtD
Sirolimus—Vomiting—Furosemide—coronary artery disease	2.17e-05	0.000144	CcSEcCtD
Sirolimus—Rash—Furosemide—coronary artery disease	2.15e-05	0.000143	CcSEcCtD
Sirolimus—Dermatitis—Furosemide—coronary artery disease	2.15e-05	0.000143	CcSEcCtD
Sirolimus—Nausea—Captopril—coronary artery disease	2.15e-05	0.000143	CcSEcCtD
Sirolimus—Headache—Furosemide—coronary artery disease	2.14e-05	0.000142	CcSEcCtD
Sirolimus—Feeling abnormal—Lisinopril—coronary artery disease	2.11e-05	0.00014	CcSEcCtD
Sirolimus—Gastrointestinal pain—Lisinopril—coronary artery disease	2.09e-05	0.000139	CcSEcCtD
Sirolimus—Vomiting—Losartan—coronary artery disease	2.09e-05	0.000139	CcSEcCtD
Sirolimus—Nausea—Perindopril—coronary artery disease	2.09e-05	0.000139	CcSEcCtD
Sirolimus—Hypersensitivity—Ramipril—coronary artery disease	2.08e-05	0.000138	CcSEcCtD
Sirolimus—Rash—Losartan—coronary artery disease	2.08e-05	0.000138	CcSEcCtD
Sirolimus—Dermatitis—Losartan—coronary artery disease	2.08e-05	0.000138	CcSEcCtD
Sirolimus—Headache—Losartan—coronary artery disease	2.06e-05	0.000137	CcSEcCtD
Sirolimus—Hypersensitivity—Timolol—coronary artery disease	2.03e-05	0.000135	CcSEcCtD
Sirolimus—Nausea—Furosemide—coronary artery disease	2.03e-05	0.000135	CcSEcCtD
Sirolimus—Asthenia—Ramipril—coronary artery disease	2.03e-05	0.000135	CcSEcCtD
Sirolimus—Body temperature increased—Lisinopril—coronary artery disease	2.03e-05	0.000134	CcSEcCtD
Sirolimus—Abdominal pain—Lisinopril—coronary artery disease	2.03e-05	0.000134	CcSEcCtD
Sirolimus—Pruritus—Ramipril—coronary artery disease	2e-05	0.000133	CcSEcCtD
Sirolimus—Asthenia—Timolol—coronary artery disease	1.98e-05	0.000132	CcSEcCtD
Sirolimus—Nausea—Losartan—coronary artery disease	1.96e-05	0.00013	CcSEcCtD
Sirolimus—Pruritus—Timolol—coronary artery disease	1.95e-05	0.00013	CcSEcCtD
Sirolimus—Diarrhoea—Ramipril—coronary artery disease	1.93e-05	0.000128	CcSEcCtD
Sirolimus—Diarrhoea—Timolol—coronary artery disease	1.89e-05	0.000125	CcSEcCtD
Sirolimus—Hypersensitivity—Lisinopril—coronary artery disease	1.89e-05	0.000125	CcSEcCtD
Sirolimus—Dizziness—Ramipril—coronary artery disease	1.87e-05	0.000124	CcSEcCtD
Sirolimus—Asthenia—Lisinopril—coronary artery disease	1.84e-05	0.000122	CcSEcCtD
Sirolimus—Dizziness—Timolol—coronary artery disease	1.83e-05	0.000121	CcSEcCtD
Sirolimus—Pruritus—Lisinopril—coronary artery disease	1.81e-05	0.00012	CcSEcCtD
Sirolimus—Vomiting—Ramipril—coronary artery disease	1.8e-05	0.000119	CcSEcCtD
Sirolimus—Rash—Ramipril—coronary artery disease	1.78e-05	0.000118	CcSEcCtD
Sirolimus—Dermatitis—Ramipril—coronary artery disease	1.78e-05	0.000118	CcSEcCtD
Sirolimus—Headache—Ramipril—coronary artery disease	1.77e-05	0.000118	CcSEcCtD
Sirolimus—Vomiting—Timolol—coronary artery disease	1.76e-05	0.000117	CcSEcCtD
Sirolimus—Diarrhoea—Lisinopril—coronary artery disease	1.75e-05	0.000116	CcSEcCtD
Sirolimus—Rash—Timolol—coronary artery disease	1.74e-05	0.000116	CcSEcCtD
Sirolimus—Dermatitis—Timolol—coronary artery disease	1.74e-05	0.000116	CcSEcCtD
Sirolimus—Headache—Timolol—coronary artery disease	1.73e-05	0.000115	CcSEcCtD
Sirolimus—Dizziness—Lisinopril—coronary artery disease	1.69e-05	0.000112	CcSEcCtD
Sirolimus—Nausea—Ramipril—coronary artery disease	1.68e-05	0.000111	CcSEcCtD
Sirolimus—Nausea—Timolol—coronary artery disease	1.64e-05	0.000109	CcSEcCtD
Sirolimus—Vomiting—Lisinopril—coronary artery disease	1.63e-05	0.000108	CcSEcCtD
Sirolimus—Rash—Lisinopril—coronary artery disease	1.62e-05	0.000107	CcSEcCtD
Sirolimus—Dermatitis—Lisinopril—coronary artery disease	1.61e-05	0.000107	CcSEcCtD
Sirolimus—Headache—Lisinopril—coronary artery disease	1.6e-05	0.000107	CcSEcCtD
Sirolimus—Nausea—Lisinopril—coronary artery disease	1.52e-05	0.000101	CcSEcCtD
Sirolimus—FKBP1A—Disease—PIK3CA—coronary artery disease	2.24e-06	2.12e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PLCB1—coronary artery disease	2.23e-06	2.12e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—CD36—coronary artery disease	2.23e-06	2.12e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—NOS3—coronary artery disease	2.23e-06	2.12e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—MMP9—coronary artery disease	2.23e-06	2.12e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—DCN—coronary artery disease	2.22e-06	2.1e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—SERPINE1—coronary artery disease	2.21e-06	2.1e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PPP2CA—coronary artery disease	2.21e-06	2.09e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—AGT—coronary artery disease	2.19e-06	2.08e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—JAK2—coronary artery disease	2.17e-06	2.06e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ABCA1—coronary artery disease	2.17e-06	2.06e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ALDH2—coronary artery disease	2.16e-06	2.05e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—HK2—coronary artery disease	2.15e-06	2.04e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—AKR1B1—coronary artery disease	2.15e-06	2.04e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—APOE—coronary artery disease	2.15e-06	2.04e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—HIF1A—coronary artery disease	2.14e-06	2.03e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—PIK3CA—coronary artery disease	2.13e-06	2.03e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—AGT—coronary artery disease	2.13e-06	2.02e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—APOA1—coronary artery disease	2.12e-06	2.02e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—MTHFR—coronary artery disease	2.12e-06	2.01e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—MAPK1—coronary artery disease	2.11e-06	2.01e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—NOS3—coronary artery disease	2.11e-06	2e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—LIPC—coronary artery disease	2.1e-06	2e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—HBA1—coronary artery disease	2.1e-06	2e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CYP2C19—coronary artery disease	2.1e-06	2e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PIK3C2A—coronary artery disease	2.1e-06	2e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—GOT1—coronary artery disease	2.1e-06	1.99e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—GGT1—coronary artery disease	2.1e-06	1.99e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—APOC3—coronary artery disease	2.09e-06	1.98e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—LEP—coronary artery disease	2.09e-06	1.98e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—APOE—coronary artery disease	2.09e-06	1.98e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—LDLR—coronary artery disease	2.08e-06	1.97e-05	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—IL6—coronary artery disease	2.07e-06	1.97e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—APOA1—coronary artery disease	2.06e-06	1.96e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—SLC27A1—coronary artery disease	2.06e-06	1.96e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL1B—coronary artery disease	2.06e-06	1.95e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GSTT1—coronary artery disease	2.05e-06	1.95e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—SLC9A1—coronary artery disease	2.05e-06	1.95e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—JAK2—coronary artery disease	2.05e-06	1.94e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—KDR—coronary artery disease	2.05e-06	1.94e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—PTGS2—coronary artery disease	2.04e-06	1.94e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.03e-06	1.93e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—MAPK14—coronary artery disease	2.03e-06	1.93e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CETP—coronary artery disease	2.03e-06	1.92e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GCLC—coronary artery disease	2.03e-06	1.92e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CPT1B—coronary artery disease	2.02e-06	1.92e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—LCAT—coronary artery disease	2.02e-06	1.92e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—AGT—coronary artery disease	2.01e-06	1.91e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—SDC1—coronary artery disease	2e-06	1.9e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—VEGFA—coronary artery disease	2e-06	1.9e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—ESR1—coronary artery disease	1.99e-06	1.89e-05	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	1.99e-06	1.89e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—TGFB1—coronary artery disease	1.99e-06	1.89e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—APOA4—coronary artery disease	1.98e-06	1.88e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—IL6—coronary artery disease	1.98e-06	1.88e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—APOE—coronary artery disease	1.97e-06	1.87e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—F2—coronary artery disease	1.97e-06	1.87e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—FN1—coronary artery disease	1.97e-06	1.87e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL6ST—coronary artery disease	1.96e-06	1.86e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—MAPK1—coronary artery disease	1.95e-06	1.85e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—APOA1—coronary artery disease	1.95e-06	1.85e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NFKBIA—coronary artery disease	1.95e-06	1.85e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PDHA1—coronary artery disease	1.92e-06	1.82e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GCLM—coronary artery disease	1.92e-06	1.82e-05	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—AKT1—coronary artery disease	1.91e-06	1.81e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PSMB5—coronary artery disease	1.89e-06	1.8e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PSMA6—coronary artery disease	1.89e-06	1.8e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—IL6—coronary artery disease	1.89e-06	1.79e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—KIT—coronary artery disease	1.88e-06	1.79e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—GSTP1—coronary artery disease	1.88e-06	1.79e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PPARG—coronary artery disease	1.87e-06	1.78e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CXCL8—coronary artery disease	1.87e-06	1.78e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PPARGC1A—coronary artery disease	1.87e-06	1.77e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—HMOX1—coronary artery disease	1.86e-06	1.76e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CYP11B2—coronary artery disease	1.86e-06	1.76e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—TXNRD1—coronary artery disease	1.86e-06	1.76e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CTGF—coronary artery disease	1.85e-06	1.76e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—POMC—coronary artery disease	1.84e-06	1.75e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TGFB1—coronary artery disease	1.84e-06	1.75e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—PIK3CA—coronary artery disease	1.83e-06	1.74e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—HMGCR—coronary artery disease	1.83e-06	1.74e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GOT2—coronary artery disease	1.83e-06	1.74e-05	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—AKT1—coronary artery disease	1.83e-06	1.74e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CAT—coronary artery disease	1.83e-06	1.74e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—SLC22A3—coronary artery disease	1.83e-06	1.74e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—AKT1—coronary artery disease	1.83e-06	1.73e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—GSK3B—coronary artery disease	1.81e-06	1.72e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—MAPK1—coronary artery disease	1.8e-06	1.71e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ARNTL—coronary artery disease	1.8e-06	1.71e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—HADH—coronary artery disease	1.8e-06	1.71e-05	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	1.8e-06	1.71e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—POMC—coronary artery disease	1.79e-06	1.7e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CREB1—coronary artery disease	1.79e-06	1.7e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CASP3—coronary artery disease	1.79e-06	1.7e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—APOB—coronary artery disease	1.78e-06	1.69e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCL2—coronary artery disease	1.76e-06	1.67e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL6R—coronary artery disease	1.75e-06	1.66e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—AKT1—coronary artery disease	1.74e-06	1.65e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CCND1—coronary artery disease	1.74e-06	1.65e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—GSTM1—coronary artery disease	1.73e-06	1.64e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IGF1—coronary artery disease	1.73e-06	1.64e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PPARG—coronary artery disease	1.72e-06	1.63e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—APOA2—coronary artery disease	1.71e-06	1.62e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	1.71e-06	1.62e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GPX2—coronary artery disease	1.71e-06	1.62e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—LPL—coronary artery disease	1.7e-06	1.61e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—PIK3CA—coronary artery disease	1.69e-06	1.61e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—POMC—coronary artery disease	1.69e-06	1.61e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—MMP9—coronary artery disease	1.69e-06	1.61e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—HK1—coronary artery disease	1.69e-06	1.6e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—SULT1A1—coronary artery disease	1.69e-06	1.6e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GPX4—coronary artery disease	1.69e-06	1.6e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ABCG5—coronary artery disease	1.69e-06	1.6e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PLCB1—coronary artery disease	1.69e-06	1.6e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—ALB—coronary artery disease	1.68e-06	1.6e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—HADHA—coronary artery disease	1.67e-06	1.58e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—GPX1—coronary artery disease	1.66e-06	1.57e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GSTA1—coronary artery disease	1.65e-06	1.56e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—SERPINE1—coronary artery disease	1.64e-06	1.56e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ABCA1—coronary artery disease	1.63e-06	1.55e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—LPA—coronary artery disease	1.63e-06	1.55e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL6—coronary artery disease	1.62e-06	1.54e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CD36—coronary artery disease	1.61e-06	1.53e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—NOS3—coronary artery disease	1.61e-06	1.53e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PPP2CA—coronary artery disease	1.59e-06	1.51e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—FGF2—coronary artery disease	1.59e-06	1.51e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GGT1—coronary artery disease	1.58e-06	1.5e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GOT1—coronary artery disease	1.58e-06	1.5e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PLCB3—coronary artery disease	1.58e-06	1.5e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—MAPK1—coronary artery disease	1.57e-06	1.49e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—PIK3CA—coronary artery disease	1.57e-06	1.49e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NOS3—coronary artery disease	1.56e-06	1.49e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—APOA5—coronary artery disease	1.56e-06	1.48e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—ALB—coronary artery disease	1.54e-06	1.47e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—P4HB—coronary artery disease	1.53e-06	1.45e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—MTHFR—coronary artery disease	1.53e-06	1.45e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—JAK2—coronary artery disease	1.52e-06	1.44e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—VEGFA—coronary artery disease	1.52e-06	1.44e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	1.5e-06	1.43e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—IL6—coronary artery disease	1.5e-06	1.42e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—AKT1—coronary artery disease	1.5e-06	1.42e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—TGFB1—coronary artery disease	1.48e-06	1.4e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—NOS3—coronary artery disease	1.48e-06	1.4e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PTGS2—coronary artery disease	1.47e-06	1.4e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—AGT—coronary artery disease	1.45e-06	1.38e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—MAPK1—coronary artery disease	1.45e-06	1.38e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—APOE—coronary artery disease	1.42e-06	1.35e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GSTP1—coronary artery disease	1.42e-06	1.35e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—VCAN—coronary artery disease	1.42e-06	1.35e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PPARGC1A—coronary artery disease	1.41e-06	1.34e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—APOA1—coronary artery disease	1.41e-06	1.34e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ALDOA—coronary artery disease	1.41e-06	1.34e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—HMOX1—coronary artery disease	1.4e-06	1.33e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TGFB1—coronary artery disease	1.39e-06	1.32e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CXCL8—coronary artery disease	1.39e-06	1.32e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IL6—coronary artery disease	1.39e-06	1.32e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—AKT1—coronary artery disease	1.38e-06	1.31e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CAT—coronary artery disease	1.38e-06	1.31e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—MAPK1—coronary artery disease	1.37e-06	1.3e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—DCN—coronary artery disease	1.37e-06	1.3e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—PIK3CA—coronary artery disease	1.36e-06	1.29e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PTGS2—coronary artery disease	1.35e-06	1.28e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—APOB—coronary artery disease	1.34e-06	1.28e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ALDH2—coronary artery disease	1.33e-06	1.26e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CASP3—coronary artery disease	1.33e-06	1.26e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GSTM1—coronary artery disease	1.31e-06	1.24e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	1.29e-06	1.23e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CYP2C19—coronary artery disease	1.29e-06	1.23e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—LIPC—coronary artery disease	1.29e-06	1.23e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—HBA1—coronary artery disease	1.29e-06	1.23e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCND1—coronary artery disease	1.29e-06	1.23e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—APOC3—coronary artery disease	1.29e-06	1.22e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—LPL—coronary artery disease	1.28e-06	1.22e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—LDLR—coronary artery disease	1.28e-06	1.21e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—AKT1—coronary artery disease	1.28e-06	1.21e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GSTT1—coronary artery disease	1.26e-06	1.2e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—SLC9A1—coronary artery disease	1.26e-06	1.2e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—PIK3CA—coronary artery disease	1.26e-06	1.19e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—MMP9—coronary artery disease	1.26e-06	1.19e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GPX1—coronary artery disease	1.25e-06	1.19e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GCLC—coronary artery disease	1.25e-06	1.19e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CETP—coronary artery disease	1.25e-06	1.19e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PPARG—coronary artery disease	1.24e-06	1.18e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—SDC1—coronary artery disease	1.24e-06	1.17e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—POMC—coronary artery disease	1.22e-06	1.16e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CD36—coronary artery disease	1.22e-06	1.16e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL6—coronary artery disease	1.21e-06	1.14e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PPP2CA—coronary artery disease	1.2e-06	1.14e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—PIK3CA—coronary artery disease	1.19e-06	1.13e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.17e-06	1.11e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.17e-06	1.11e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—MTHFR—coronary artery disease	1.15e-06	1.1e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CTGF—coronary artery disease	1.14e-06	1.08e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GOT2—coronary artery disease	1.13e-06	1.07e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.13e-06	1.07e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—VEGFA—coronary artery disease	1.13e-06	1.07e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ALB—coronary artery disease	1.12e-06	1.06e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—IL6—coronary artery disease	1.11e-06	1.06e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—AKT1—coronary artery disease	1.11e-06	1.06e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—AGT—coronary artery disease	1.1e-06	1.04e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—APOE—coronary artery disease	1.08e-06	1.02e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—NOS3—coronary artery disease	1.07e-06	1.01e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—APOA1—coronary artery disease	1.06e-06	1.01e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL6—coronary artery disease	1.05e-06	9.97e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.04e-06	9.86e-06	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TGFB1—coronary artery disease	1.03e-06	9.82e-06	CbGpPWpGaD
Sirolimus—MTOR—Disease—AKT1—coronary artery disease	1.03e-06	9.75e-06	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—MAPK1—coronary artery disease	1.01e-06	9.63e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.01e-06	9.56e-06	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PTGS2—coronary artery disease	9.76e-07	9.27e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GGT1—coronary artery disease	9.75e-07	9.26e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GOT1—coronary artery disease	9.75e-07	9.26e-06	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—AKT1—coronary artery disease	9.69e-07	9.2e-06	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PPARG—coronary artery disease	9.36e-07	8.89e-06	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—POMC—coronary artery disease	9.24e-07	8.77e-06	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PIK3CA—coronary artery disease	9.05e-07	8.59e-06	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—PIK3CA—coronary artery disease	8.8e-07	8.36e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GSTP1—coronary artery disease	8.76e-07	8.32e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	8.68e-07	8.24e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—HMOX1—coronary artery disease	8.64e-07	8.2e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CAT—coronary artery disease	8.52e-07	8.09e-06	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ALB—coronary artery disease	8.42e-07	7.99e-06	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PIK3CA—coronary artery disease	8.31e-07	7.89e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—APOB—coronary artery disease	8.28e-07	7.86e-06	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—NOS3—coronary artery disease	8.05e-07	7.65e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GSTM1—coronary artery disease	8.05e-07	7.64e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—LPL—coronary artery disease	7.9e-07	7.5e-06	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL6—coronary artery disease	7.79e-07	7.4e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GPX1—coronary artery disease	7.71e-07	7.32e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CD36—coronary artery disease	7.51e-07	7.13e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PPP2CA—coronary artery disease	7.41e-07	7.04e-06	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—AKT1—coronary artery disease	7.4e-07	7.02e-06	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PTGS2—coronary artery disease	7.37e-07	6.99e-06	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—AKT1—coronary artery disease	7.19e-07	6.83e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—MTHFR—coronary artery disease	7.11e-07	6.75e-06	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—AKT1—coronary artery disease	6.79e-07	6.44e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—AGT—coronary artery disease	6.76e-07	6.42e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—APOE—coronary artery disease	6.62e-07	6.29e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—APOA1—coronary artery disease	6.55e-07	6.22e-06	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PIK3CA—coronary artery disease	6.01e-07	5.7e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PPARG—coronary artery disease	5.77e-07	5.48e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—POMC—coronary artery disease	5.69e-07	5.4e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ALB—coronary artery disease	5.19e-07	4.92e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—NOS3—coronary artery disease	4.96e-07	4.71e-06	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—AKT1—coronary artery disease	4.91e-07	4.66e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PTGS2—coronary artery disease	4.54e-07	4.31e-06	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PIK3CA—coronary artery disease	4.53e-07	4.3e-06	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—AKT1—coronary artery disease	3.7e-07	3.51e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PIK3CA—coronary artery disease	2.79e-07	2.65e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—AKT1—coronary artery disease	2.28e-07	2.17e-06	CbGpPWpGaD
